MedPath

Effect of Omega-3 on pruritus scale in hemodialysis patients

Phase 2
Conditions
End Stage Renal Disease.
End Stage Renal Disease
Registration Number
IRCT201311152417N14
Lead Sponsor
Vice Chancell for Research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

consent for cooperation; hemodialysis for at least 3 months; pruritus duration > 8 weeks; without any dermatologic problems; no hypersensitivity to omega-3; no malabsorption or other gastrointestinal problems (chronic diarrhea >2 weeks); not using anticoagulant and antiplatelet drugs.
Exclusion criteria: incompliance; kidney transplantation; antihistamin or Gabapentin using; anemia (Hb<7g/dL ); PTH > 300microg/L ; Phosphorus >7mg/dL ; INR rising

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath